MHC-I Binding Prediction Ensemble for Epitope Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for predicting major histocompatibility complex class I (MHC-I) binding are not robustly sensitive, specific, and accurate, limiting the identification of candidate epitopes for immunotherapy targets such as viruses and cancer.
Innovation Solution
A method involving training machine learning models using binding affinity data from mass spectrometry-identified peptides and combining multiple algorithms to predict consensus MHC-I binding, which includes selecting peptides for vaccine compositions and determining population fitness based on allele preferences and expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current MHC-I binding prediction methods are used, then prediction can be performed, but accuracy, sensitivity, and specificity are insufficient
Solution Approach 1:
The patent combines multiple machine learning prediction models (netMHCpan, MHCflurry, MixMHCpred) into an ensemble system that integrates their outputs. This merging of multiple prediction approaches resolves the contradiction by achieving both high accuracy through model diversity and high reliability through consensus agreement, where peptides predicted by multiple models are more confidently identified as true binders.
Solution Approach 2:
The system incorporates iterative refinement where prediction results are compared against known MHC-I ligand databases and experimental data. The model parameters are adjusted based on feedback from prediction performance metrics, thereby simultaneously improving both accuracy (through parameter optimization) and reliability (through validation against ground truth data).
2Measurement precision
If multiple machine learning models are combined to improve prediction accuracy, then candidate epitope identification improves, but computational complexity increases
Solution Approach 1:
The patent segments the prediction task by assigning different machine learning models to predict different aspects of MHC-I binding (affinity, stability, immunogenicity). Each model handles a specific segment of the prediction problem, improving overall accuracy while managing complexity through functional decomposition. The ensemble system processes predictions in modular stages rather than as a monolithic complex system.
Solution Approach 2:
The ensemble prediction system serves multiple functions simultaneously: it predicts binding affinity, stabilizes peptide-MHC complexes, and identifies immunogenic epitopes. By making the system multi-functional, it achieves comprehensive epitope identification accuracy without requiring separate specialized systems for each function, thereby managing overall complexity while improving predictive power.
Data Source
AI summary
A consensus MHC-I binding and processing prediction workflow, methods and systems are described, for improving T-cell immunity against threats such as viruses and cancer. The methods and systems can also be used to determine population fitness against a target antigen such as a pathogen or cancer.